|
|
Volumn 20, Issue 2, 2013, Pages 226-229
|
|
Management of severe recurrent focal segmental glomerulosclerosis through circulating soluble urokinase receptor modification
|
|
Author keywords
Apheresis; Circulating factor; FSGS; Transplantation
|
|
Indexed keywords
2 AMINO 5 PHOSPHONOVALERIC ACID;
ALBUMIN;
BETA3 INTEGRIN;
CREATININE;
FRESH FROZEN PLASMA;
RITUXIMAB;
UROKINASE RECEPTOR;
ADULT;
ARTICLE;
BIOASSAY;
CASE REPORT;
CLINICAL EFFECTIVENESS;
CREATININE BLOOD LEVEL;
DELAYED GRAFT FUNCTION;
DISEASE COURSE;
DISEASE SEVERITY;
DIURESIS;
ELECTRON MICROSCOPY;
FEMALE;
FOCAL GLOMERULOSCLEROSIS;
HEMODIALYSIS;
HIGH RISK PATIENT;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
HYDRAULIC PERMEABILITY;
IMMUNOADSORPTION;
KIDNEY BIOPSY;
KIDNEY TRANSPLANTATION;
MEDICAL DEVICE;
OLIGURIA;
PLASMAPHERESIS;
PODOCYTE;
POSTOPERATIVE CARE;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
PROTEINURIA;
RECURRENT DISEASE;
REPEAT PROCEDURE;
URINE VOLUME;
BIOLOGICAL MARKERS;
FEMALE;
GLOMERULOSCLEROSIS, FOCAL SEGMENTAL;
HUMANS;
IMMUNOSORBENT TECHNIQUES;
INTEGRIN BETA3;
MIDDLE AGED;
PLASMAPHERESIS;
PODOCYTES;
PROTEINURIA;
RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR;
RECURRENCE;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
|
EID: 84875188953
PISSN: 10752765
EISSN: 15363686
Source Type: Journal
DOI: 10.1097/MJT.0b013e3182811aca Document Type: Article |
|
Times cited : (24)
|
|
References (3)
|
